161 related articles for article (PubMed ID: 2438592)
21. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
22. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935.
Mennicken F; Savasta M; Peretti-Renucci R; Feuerstein C
J Neural Transm Gen Sect; 1992; 87(1):1-14. PubMed ID: 1346964
[TBL] [Abstract][Full Text] [Related]
23. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat.
Gerfen CR
J Comp Neurol; 1985 Jun; 236(4):454-76. PubMed ID: 2414339
[TBL] [Abstract][Full Text] [Related]
24. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
Bolam JP; Smith Y
Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
[TBL] [Abstract][Full Text] [Related]
25. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
[TBL] [Abstract][Full Text] [Related]
26. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque.
Hedreen JC; DeLong MR
J Comp Neurol; 1991 Feb; 304(4):569-95. PubMed ID: 2013650
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
28. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
29. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
30. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.
Szigethy E; Beaudet A
J Comp Neurol; 1989 Jan; 279(1):128-37. PubMed ID: 2563267
[TBL] [Abstract][Full Text] [Related]
31. The nigrostriatal projection in the cat. Part 1. Silver impregnation study.
Usunoff KG; Hassler R; Romansky K; Usunova P; Wagner A
J Neurol Sci; 1976 Jul; 28(3):265-88. PubMed ID: 932775
[TBL] [Abstract][Full Text] [Related]
32. Dopamine innervation of the monkey mediodorsal thalamus: Location of projection neurons and ultrastructural characteristics of axon terminals.
Melchitzky DS; Erickson SL; Lewis DA
Neuroscience; 2006 Dec; 143(4):1021-30. PubMed ID: 17029800
[TBL] [Abstract][Full Text] [Related]
33. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
[TBL] [Abstract][Full Text] [Related]
34. Non-dopaminergic nigrostriatal pathway.
Guyenet PG; Crane JK
Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
[TBL] [Abstract][Full Text] [Related]
35. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain.
Patel S; Roberts J; Moorman J; Reavill C
Neuroscience; 1995 Dec; 69(4):1159-67. PubMed ID: 8848104
[TBL] [Abstract][Full Text] [Related]
36. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
Janson AM; Fuxe K
Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
[TBL] [Abstract][Full Text] [Related]
37. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
[TBL] [Abstract][Full Text] [Related]
38. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons.
Burke RE; Macaya A; DeVivo D; Kenyon N; Janec EM
Neuroscience; 1992 Oct; 50(3):559-69. PubMed ID: 1359461
[TBL] [Abstract][Full Text] [Related]
39. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
Herkenham M; Lynn AB; de Costa BR; Richfield EK
Brain Res; 1991 May; 547(2):267-74. PubMed ID: 1909204
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
Filloux FM; Wamsley JK; Dawson TM
Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
